Unraveling Chemotherapy Resistance: Linking Tumor Metabolism, Cachexia, and Organoid InnovationMosamatic™: The Leading Solution for Automated Body Composition Analysis

Cancer cachexia is associated with pronounced body composition alterations. Utilizing routine diagnostic CT imaging, we focus on detailed analysis of skeletal muscle mass, muscle quality, and adipose tissue volume. This comprehensive approach helps us understand how changes in body composition affect disease progression and patient outcomes.

Mosamatic™ is the best-validated tool for automated body composition analysis, designed to bring accuracy and efficiency to medical imaging research and clinical practice. Whether you’re a clinician, researcher, or industry partner, Mosamatic™ empowers you to extract detailed muscle and fat metrics from CT scans with ease.

What Mosamatic™ Offers:

• Comprehensive Documentation: Access clear guides on installation, usage, and best practices for integrating Mosamatic™ with your own imaging data.
• Advanced Analytical Capabilities: Mosamatic™ leverages deep learning to automatically segment muscle and fat tissue, calculate key body composition metrics, and support large-scale studies across diverse patient populations.
• User-Friendly Web Interface: The intuitive web-based platform streamlines the analysis process, enabling users to upload scans, perform segmentations, and review results—all within a browser environment.
• Seamless Integration: Compatible with existing clinical imaging software and infrastructure, Mosamatic™ can be used independently or alongside other tools to facilitate research and clinical workflows.
• Open Access for Research: Freely available for scientific use, Mosamatic™ supports collaboration and contract research, making advanced body composition analysis accessible to the broader medical community.